Report
Niclas Gehin ...
  • Nicolai Farstad Olsen
  • Ole-Andreas Krohn
  • Simen Mortensen
Underlyings
B2Holding ASA

B2holding ASA. B2holding ASA is a Norway-based company, which is primarily focused on the financial services industry. The Company operates as a provider of debt solutions for banks and institutional vendors. The Company operates in five segments, namely: Debt Purchase, Debt Collection, Credit Information, Third Party Debt Collection, Consumer Lending. The Debt Purchase segment is involved in the purchasing debt portfolios, in particular Non-performing loans (NPLs). The Debt Collection segment provides optimal collections through amicable solutions or legal processes. The Credit Information segment offers credit information as a service through Creditreform in Latvia. The Third Party Debt Collection offers collection of debt on behalf of customers. The Consumer Lending segment provides lending services. The Company operates on Danish market through Nordic Debt Collection A/S (Nodeco), as well as owns a majority stake in Spanish entity Confirmacionde Solicitudes de Credito Verifica.

DOF ASA

DOF is the parent company in DOF's group of companies which owns and operates a fleet of supply and subsea vessels as well as having the engineering capacity to service the subsea market. Co. operates worldwide and provides services to the global oil and gas industry. Co. operates in three segments of the offshore service market. These are defined by types of activities and vessel types: Platform Supply Vessels, Anchor Handling Tug Supply Vessels and Subsea Vessels and Subsea Engineering. The subsea engineering activities among others comprise Survey and Positioning, Inspection, Repair and Maintenance Services, Construction Support, Diving Services and Mooring Projects.

Solon Eiendom ASA

Solon Eiendom is a biotechnology company. Co.'s focus is the research and development of peptide based vaccines against viral diseases, primarily human immunodeficiency virus (HIV). As of Dec 31 2013, Co.'s clinical development pipeline comprised of two vaccine candidates for the treatment of HIV, Vacc-4X and Vacc-C5. Vacc-4X is being investigated in two phases II trials in collaboration with Celgene Inc.

Provider
DnB Markets
DnB Markets

DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.

 

Analysts
Niclas Gehin

Nicolai Farstad Olsen

Ole-Andreas Krohn

Simen Mortensen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch